SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-262140
Filing Date
2022-10-13
Accepted
2022-10-13 16:01:37
Documents
12
Period of Report
2022-10-10
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K d412468d8k.htm   iXBRL 8-K 23912
  Complete submission text file 0001193125-22-262140.txt   144898

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA acad-20221010.xsd EX-101.SCH 2874
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE acad-20221010_lab.xml EX-101.LAB 17997
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acad-20221010_pre.xml EX-101.PRE 11274
6 EXTRACTED XBRL INSTANCE DOCUMENT d412468d8k_htm.xml XML 3407
Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

IRS No.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50768 | Film No.: 221309134
SIC: 2834 Pharmaceutical Preparations